PURPOSE: To determine the outcome of patients who underwent pancreatic head resection and Roux-en-Y pancreaticojejunostomy to the remaining normal pancreatic body and tail for the treatment of a focal lesion in the pancreatic head causing congenital hyperinsulinism (HI). METHODS: One hundred thirty-eight patients underwent pancreatic resection for focal HI between 1998 and 2010. Twenty-three patients in the group underwent pancreatic head resection and Roux-en-Y pancreaticojejunostomy. RESULTS: There were 13 females and 10 males. Median age and weight at surgery were 8 weeks and 5.8 kg, respectively. Twenty-one patients had a near-total pancreatic head resection, and 2 patients had a pylorus-preserving Whipple procedure. The pancreaticojejunostomy anastomosis was performed with interrupted fine monofilament sutures such that the transected end of the pancreatic body was tucked within the end of the Roux-en-Y jejunal limb. Median hospital stay was 22 days. All patients were cured of HI. CONCLUSION: We conclude that pancreatic head resection with Roux-en-Y pancreaticojejunostomy is a safe and effective procedure for the treatment of the HI patient with a large focal lesion in the pancreatic head that is not amenable to local resection alone.
PURPOSE: To determine the outcome of patients who underwent pancreatic head resection and Roux-en-Y pancreaticojejunostomy to the remaining normal pancreatic body and tail for the treatment of a focal lesion in the pancreatic head causing congenital hyperinsulinism (HI). METHODS: One hundred thirty-eight patients underwent pancreatic resection for focal HI between 1998 and 2010. Twenty-three patients in the group underwent pancreatic head resection and Roux-en-Y pancreaticojejunostomy. RESULTS: There were 13 females and 10 males. Median age and weight at surgery were 8 weeks and 5.8 kg, respectively. Twenty-one patients had a near-total pancreatic head resection, and 2 patients had a pylorus-preserving Whipple procedure. The pancreaticojejunostomy anastomosis was performed with interrupted fine monofilament sutures such that the transected end of the pancreatic body was tucked within the end of the Roux-en-Y jejunal limb. Median hospital stay was 22 days. All patients were cured of HI. CONCLUSION: We conclude that pancreatic head resection with Roux-en-Y pancreaticojejunostomy is a safe and effective procedure for the treatment of the HIpatient with a large focal lesion in the pancreatic head that is not amenable to local resection alone.
Authors: Timo Otonkoski; Kirsti Näntö-Salonen; Marko Seppänen; Riitta Veijola; Hanna Huopio; Khalid Hussain; Päivi Tapanainen; Olli Eskola; Riitta Parkkola; Klas Ekström; Yves Guiot; Jacques Rahier; Markku Laakso; Risto Rintala; Pirjo Nuutila; Heikki Minn Journal: Diabetes Date: 2006-01 Impact factor: 9.461
Authors: Charles A Stanley; Paul S Thornton; Arupa Ganguly; Courtney MacMullen; Patricia Underwood; Pooja Bhatia; Linda Steinkrauss; Laura Wanner; Robin Kaye; Eduardo Ruchelli; Mariko Suchi; N Scott Adzick Journal: J Clin Endocrinol Metab Date: 2004-01 Impact factor: 5.958
Authors: William H Peranteau; Andrew A Palladino; Tricia R Bhatti; Susan A Becker; Lisa J States; Charles A Stanley; N Scott Adzick Journal: J Pediatr Surg Date: 2013-12 Impact factor: 2.545
Authors: N Scott Adzick; Diva D De Leon; Lisa J States; Katherine Lord; Tricia R Bhatti; Susan A Becker; Charles A Stanley Journal: J Pediatr Surg Date: 2018-10-05 Impact factor: 2.545
Authors: Julie Bendix; Mette G Laursen; Michael B Mortensen; Maria Melikian; Evgenia Globa; Sönke Detlefsen; Lars Rasmussen; Henrik Petersen; Klaus Brusgaard; Henrik T Christesen Journal: Front Endocrinol (Lausanne) Date: 2018-08-22 Impact factor: 5.555